SBIR/STTR Research Award

GABA PATHWAY ANTIBODIES DERIVED FROM A HYBRIDOMA LIBRARY

Award identifier b76f87ec6df29f86c9cff89f55f27e5c1b7b001cc2e210b268acf33f94c64635Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$99,905

Program and phase

SBIR · Phase I

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
IMGENEX
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Efforts to sequence various genomes have provided a wealth of new biological data, but have exacerbated a growing deficit in tools to study protein function and interrelationships. This may be particularly true in neurobiology where many new pathways have been identified, but reagents, such as antibodies, still do not exist for well-known pathway members. For example, proteins involved in the regulation of GABA are known to be important in human neurological disorders, but few antibody reagents for their study exist. To address these needs and create a means for scientists to isolate antibodies of their own choosing, we intend to create a monoclonal antibody-producing, whole cell antigen hybridoma library and antibody microarrays representative of the library. This initial library will be derived from rat brain cells, and may allow discovery of new diagnostic or therapeutic targets; future libraries can target other species or tissue types. The microarrays produced from the library will be available to scientists worldwide for individual screening; subsequent secondary screening will produce cloned novel antibodies. Thus, two major needs are served with this proposal: a renewable, screenable, and shareable source of novel research reagent antibodies, and a means of broad-based production and discovery of tissue type-specific antibodies. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.